Lista de obras -

A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer ⬇️

artículo científico publicado el 1 de diciembre de 2013

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.

artículo científico publicado en 2008

A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer

artículo científico publicado en 2009

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321

artículo científico publicado en 2015

Adaptive Randomization of Neratinib in Early Breast Cancer

artículo científico publicado en 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

artículo científico publicado en 2016

Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway

artículo científico

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

artículo científico publicado en 2019

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

artículo científico publicado en 2014

Clinical utility of gene expression profiling data for clinical decision-making regarding adjuvant therapy in early stage, node-negative breast cancer: a case report

artículo científico publicado en 2012

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

artículo científico publicado en 2013

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

artículo científico publicado en 2017

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

artículo científico publicado en 2015

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

artículo científico publicado en 2017

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

artículo científico publicado en 2017

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

artículo científico publicado en 2014

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

artículo científico publicado en 2015

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

artículo científico publicado en 2015

Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine

artículo científico publicado en 2015

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

artículo científico publicado en 2015

Intersection of cardiology and oncology clinical practices

artículo científico publicado en 2014

Live, attenuated varicella zoster vaccination of an immunocompromised patient

artículo científico publicado en 2008

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

artículo científico publicado en 2019

Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

artículo científico publicado en 2010

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

artículo científico publicado en 2012

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

artículo científico publicado en 2014

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer

artículo científico publicado en 2014

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

artículo científico publicado en 2009

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma

artículo científico publicado en 2007

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

scientific article published on 21 November 2019

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer ⬇️

artículo científico publicado el 27 de septiembre de 2011

Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer

artículo científico publicado en 2014

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

artículo científico publicado en 2015

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors

artículo científico publicado en 2014

Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies ⬇️

artículo científico publicado el 31 de marzo de 2013

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors

artículo científico publicado en 2014

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial ⬇️

artículo científico publicado el 5 de julio de 2013

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

artículo científico publicado en 2012

Posttransplant Lymphoproliferative Disorder: Otolaryngological Manifestations and Management

artículo científico

Quality of life and disease understanding: impact of attending a patient-centered cancer symposium

artículo científico publicado en 2015

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.

artículo científico publicado en 2013

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

artículo científico publicado en 2017

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

artículo científico publicado en 2017

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

artículo científico publicado en 2013

The impact of obesity on breast cancer: a retrospective review.

artículo científico publicado en 2012

Trastuzumab-induced cardiotoxicity: heart failure at the crossroads

artículo científico publicado en 2008

Triple-negative breast cancers: unique clinical presentations and outcomes

artículo científico publicado en 2010

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

artículo científico publicado en 2017

Use of liposomal anthracyclines in Kaposi's sarcoma

artículo científico publicado en 2004

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

artículo científico publicado en 2010

Lista de obras de

A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer ⬇️

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.

A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321

Adaptive Randomization of Neratinib in Early Breast Cancer

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

Clinical utility of gene expression profiling data for clinical decision-making regarding adjuvant therapy in early stage, node-negative breast cancer: a case report

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

Intersection of cardiology and oncology clinical practices

Live, attenuated varicella zoster vaccination of an immunocompromised patient

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer ⬇️

Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors

Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies ⬇️

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial ⬇️

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

Posttransplant Lymphoproliferative Disorder: Otolaryngological Manifestations and Management

Quality of life and disease understanding: impact of attending a patient-centered cancer symposium

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

The impact of obesity on breast cancer: a retrospective review.

Trastuzumab-induced cardiotoxicity: heart failure at the crossroads

Triple-negative breast cancers: unique clinical presentations and outcomes

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Use of liposomal anthracyclines in Kaposi's sarcoma

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer